A French company is looking for a co-development agreement for its anti cancer small molecule

Summary:

A French company is developing a novel molecule to be used as a first or second line in the treatment of chemoresistant cancers.

The company is looking for technical cooperation agreements with biotech and pharmaceutical partners with complementary expertise.

Reference: TRFR20170807001

Country: France

Submitted: 10. 11. 2017

View Partnering Opportunity

Keywords

Technology: Cytology-Cancerology-Oncology, Medical Research, Biology / Biotechnology

Market: Oncology, Pharmaceuticals/fine chemicals

NACE: Research and experimental development on biotechnology

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.